BRPI0311934B1 - Composição, solução, e uso de uma composição para tratar estresse em uma ave - Google Patents

Composição, solução, e uso de uma composição para tratar estresse em uma ave Download PDF

Info

Publication number
BRPI0311934B1
BRPI0311934B1 BRPI0311934-3A BR0311934A BRPI0311934B1 BR PI0311934 B1 BRPI0311934 B1 BR PI0311934B1 BR 0311934 A BR0311934 A BR 0311934A BR PI0311934 B1 BRPI0311934 B1 BR PI0311934B1
Authority
BR
Brazil
Prior art keywords
bird
acid
composition
chickens
derivatives
Prior art date
Application number
BRPI0311934-3A
Other languages
English (en)
Portuguese (pt)
Other versions
BR0311934A (pt
Inventor
Patrick Pageat
Original Assignee
Fideline
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fideline filed Critical Fideline
Publication of BR0311934A publication Critical patent/BR0311934A/pt
Publication of BRPI0311934B1 publication Critical patent/BRPI0311934B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A61P5/16—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4 for decreasing, blocking or antagonising the activity of the thyroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Anesthesiology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)
BRPI0311934-3A 2002-06-19 2003-06-19 Composição, solução, e uso de uma composição para tratar estresse em uma ave BRPI0311934B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38976802P 2002-06-19 2002-06-19
EP02291533 2002-06-19
PCT/EP2003/007144 WO2004000336A1 (en) 2002-06-19 2003-06-19 Avian appeasing pheromones to decrease stress, anxiety and aggressiveness

Publications (2)

Publication Number Publication Date
BR0311934A BR0311934A (pt) 2005-04-05
BRPI0311934B1 true BRPI0311934B1 (pt) 2015-05-26

Family

ID=42635094

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0311934-3A BRPI0311934B1 (pt) 2002-06-19 2003-06-19 Composição, solução, e uso de uma composição para tratar estresse em uma ave

Country Status (12)

Country Link
EP (1) EP1531839B1 (https=)
JP (1) JP4863619B2 (https=)
CN (1) CN100508968C (https=)
AT (1) ATE468123T1 (https=)
AU (1) AU2003246372B8 (https=)
BR (1) BRPI0311934B1 (https=)
CA (1) CA2490681C (https=)
DK (1) DK1531839T3 (https=)
ES (1) ES2345099T3 (https=)
MX (1) MXPA04013005A (https=)
PT (1) PT1531839E (https=)
WO (1) WO2004000336A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6629286B2 (ja) * 2014-03-18 2020-01-15 アンスティテュ・ドゥ・ルシェルシュ・アン・セミオシミー・エ・エソロジー・アプリケＩｎｓｔｉｔｕｔ Ｄｅ Ｒｅｃｈｅｒｃｈｅ Ｅｎ Ｓｅｍｉｏｃｈｉｍｉｅ Ｅｔ Ｅｔｈｏｌｏｇｉｅ Ａｐｐｌｉｑｕｅｅ ネコ鎮静フェロモン
AU2016221929A1 (en) * 2015-02-20 2017-07-13 Société des Produits Nestlé S.A. Medium chain fatty acids and their triglycerides for treating anxiety
US9943480B2 (en) * 2015-11-03 2018-04-17 Wisconsin Alumni Research Foundation Compositions containing preen oil and methods of use thereof
BE1023693B1 (nl) * 2016-06-15 2017-06-16 Vervaeke-Belavi Nv Werkwijze voor het produceren van kuikens
EP3727457B1 (fr) 2017-12-22 2025-08-20 Ceva Santé Animale Diffuseurs de composition de semio-chimiques régulés en fonction de la température
CN117919345A (zh) * 2023-12-21 2024-04-26 宁波三生生物科技股份有限公司 一种信息素组合物及其制备方法
CN120938981A (zh) * 2025-10-20 2025-11-14 宁波三生生物科技股份有限公司 一种信息素组合物及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3039817B2 (ja) * 1990-09-28 2000-05-08 株式会社資生堂 シャンプー組成物
US5272134A (en) * 1992-03-24 1993-12-21 Erox Corporation Fragrance compositions and other compositions which contain human pheromones
FR2715069B1 (fr) * 1994-01-20 1996-04-05 Rene Laversanne Procédé pour améliorer la rémanence d'une odeur.
DE19511572C2 (de) * 1995-03-29 1998-02-26 Henkel Kgaa Niedrigviskose Trübungsmittelkonzentrate
DE19615777C2 (de) * 1996-04-20 1999-04-01 Henkel Kgaa Verwendung von Milchsäure-Milchsäureester-Mischungen
GB9720814D0 (en) * 1997-10-01 1997-12-03 Kiotech Limited Pheromone composition
JP4754688B2 (ja) * 1998-01-21 2011-08-24 フィドゥラン ストレス、不安及び攻撃性を低減するブタ鎮静フェロモン
US6054481A (en) * 1998-01-21 2000-04-25 Fideline Pig appeasing pheromones for enhancing weight gain in a mammal
NO308197B1 (no) * 1998-01-21 2000-08-14 Fideline Sammensetning og oppløsning derav for Õ minske stress, angst og agressivitet hos pattedyr inneholdende en blanding av fettsyrer eller derivater derav
DK1382343T3 (da) * 1998-11-02 2010-04-26 Gilead Sciences Inc Kombinationsterapi til behandling af hepatitis B-virus

Also Published As

Publication number Publication date
AU2003246372B8 (en) 2009-03-26
DK1531839T3 (da) 2010-09-13
JP2006508038A (ja) 2006-03-09
BR0311934A (pt) 2005-04-05
CA2490681C (en) 2012-01-24
CN1668318A (zh) 2005-09-14
ATE468123T1 (de) 2010-06-15
CN100508968C (zh) 2009-07-08
EP1531839A1 (en) 2005-05-25
WO2004000336A1 (en) 2003-12-31
EP1531839B1 (en) 2010-05-19
PT1531839E (pt) 2010-07-21
JP4863619B2 (ja) 2012-01-25
AU2003246372B2 (en) 2008-11-27
MXPA04013005A (es) 2005-09-12
CA2490681A1 (en) 2003-12-31
AU2003246372A1 (en) 2004-01-06
ES2345099T3 (es) 2010-09-15

Similar Documents

Publication Publication Date Title
JP4750232B2 (ja) ストレス、不安および攻撃性を低減するブタ鎮静フェロモン
Nelson et al. Minireview The influence of season, photoperiod, and pineal melatonin on immune function
Louch Adrenocortical activity in relation to the density and dynamics of three confined populations of Microtus pennsylvanicus
Cheng et al. Chronic social stress differentially regulates neuroendocrine responses in laying hens: II. Genetic basis of adrenal responses under three different social conditions
Nicol et al. Farmed bird welfare science review
US20240123006A1 (en) Methods of selectively promoting animal welfare through modulation of microbiome
US7723388B2 (en) Avian appeasing pheromones to decrease stress, anxiety and aggressiveness
BRPI0311934B1 (pt) Composição, solução, e uso de uma composição para tratar estresse em uma ave
Bedada et al. The neuropsychopharmacological effects of Catha edulis in mice offspring born to mothers exposed during pregnancy and lactation
JP4754688B2 (ja) ストレス、不安及び攻撃性を低減するブタ鎮静フェロモン
Villagrá et al. Stocking density and stress induction affect production and stress parameters in broiler chickens
Salamon Maternal investment-and its constraints-in the egg of domestic waterfowl
Clubb et al. Health and reproductive assessment of selected Puerto Rican parrots (Amazona vittata) in captivity
Meisel Effects of postweaning rearing condition on recovery of copulatory behavior from lesions of the medial preoptic area in rats
Uriarte et al. Effects of litter‐overlapping on emotionality, stress response, and reproductive functions in male and female rats
Madec et al. Broilers (Gallus gallus) are less stressed if they can smell a mother odorant
Akinwemoye et al. Effects of in ovo electrolyte feeding and delayed placement on post-hatch chick quality, yolk sac utilization, and gut organ weight in neonatal broiler chicks
Taylor et al. The laboratory bird
Daini et al. Influence of in ovo administration of oyster mushroom extract on morphological and histological responses of intestines of broiler chickens.
DAINI et al. INFLUENCE OF IN OVO ADMINISTRATION OF OYSTER MUSHROOM EXTRACT ON MORPHOLOGICAL AND HISTOLOGICAL CHARACTERISTICS OF INTESTINES OF BROILER CHICKENS.
Mills Skeletal muscle characteristics of commercial and traditional strains of turkey
Kozanoğlu et al. The effect of exogenous melatonin administration on sperm quality and some stress related parameters of broiler breeder males under natural summer conditions.
JANWARI MASTER OF VETERINARY SCIENCES
Lonardi PAIN ASSESSMENT METHODS: THE CASE OF SURGICAL CASTRATION IN PIGLETS
Engel Adaptation to social isolation

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 26/05/2015, OBSERVADAS AS CONDICOES LEGAIS.

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 26/05/2025